(TGTX) - Analyzing TG Therapeutics's Short Interest
Portfolio Pulse from Benzinga Insights
TG Therapeutics (NYSE:TGTX) has seen a decrease in short interest, now at 23.68% of float, lower than its last report. The short interest represents 29.12 million shares, with a cover time of 7.19 days. This decline in short interest could indicate a more bullish sentiment towards TGTX, despite it having higher short interest than its peer group average of 13.57%.
March 13, 2024 | 7:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
TG Therapeutics has experienced a decrease in short interest, indicating a potential shift towards a more bullish market sentiment.
A decrease in short interest typically suggests that investors are becoming more optimistic about a stock's future performance. Given that TGTX's short interest has fallen and is now lower than its last report, this could lead to a short-term positive impact on its stock price. However, it's important to note that short interest is just one of many factors that can influence stock prices.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90